INTELLIA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
INTELLIA THERAPEUTICS, INC. (NTLA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $14.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.42M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $12.97M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $8.69M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $23.04M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $26.35M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$5.18M, a 119.08% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $27.17M, a 1157.78% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.16M, a 77.95% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 8 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.39M 10-Q · filed 2026-08-06 | $23.08M derived: sum of 3 quarters · filed 2026-08-06 | $46.12M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $12.97M 10-Q · filed 2026-05-11 | $21.66M derived: sum of 2 quarters · filed 2026-05-11 | $44.70M derived: sum of 3 quarters · filed 2026-05-11 | $39.54M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.73M derived: sum of 2 quarters · filed 2026-02-26 | $26.57M derived: sum of 3 quarters · filed 2026-08-06 | $26.35M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $23.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.88M derived: sum of 2 quarters · filed 2026-08-06 | $17.66M 10-Q · filed 2025-11-06 | $17.12M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$5.37M 10-Q · filed 2026-08-06 | -$5.91M derived: sum of 3 quarters · filed 2026-08-06 | -$16.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$218.00K 10-Q · filed 2026-05-11 | -$759.00K derived: sum of 2 quarters · filed 2026-05-11 | -$11.64M derived: sum of 3 quarters · filed 2026-05-11 | -$14.15M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$11.42M derived: sum of 2 quarters · filed 2026-02-26 | -$13.93M derived: sum of 3 quarters · filed 2026-02-26 | -$5.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$10.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$13.39M derived: sum of 2 quarters · filed 2025-11-06 | -$4.64M 10-Q · filed 2025-11-06 | $10.72M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.24M 10-Q · filed 2025-08-07 | $21.60M derived: sum of 3 quarters · filed 2026-02-26 | $27.33M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $8.75M 10-Q · filed 2025-05-08 | $24.11M derived: sum of 2 quarters · filed 2026-02-26 | $29.84M derived: sum of 3 quarters · filed 2026-02-26 | $31.10M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $15.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.09M derived: sum of 2 quarters · filed 2026-02-26 | $22.35M derived: sum of 3 quarters · filed 2026-02-26 | $27.17M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.99M derived: sum of 2 quarters · filed 2024-11-07 | $11.81M 10-Q · filed 2024-11-07 | $13.74M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.08M 10-Q · filed 2024-08-08 | $8.01M derived: sum of 3 quarters · filed 2025-02-27 | $8.67M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $4.82M 10-Q · filed 2024-05-09 | $6.75M derived: sum of 2 quarters · filed 2025-02-27 | $7.41M derived: sum of 3 quarters · filed 2025-02-27 | $7.40M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.59M derived: sum of 2 quarters · filed 2025-02-27 | $2.58M derived: sum of 3 quarters · filed 2025-02-27 | $2.16M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $662.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $650.00K derived: sum of 2 quarters · filed 2023-11-09 | $228.00K 10-Q · filed 2023-11-09 | $4.95M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$434.00K 10-Q · filed 2023-08-03 | $4.29M derived: sum of 3 quarters · filed 2024-02-22 | $661.00K derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | -$422.00K 10-Q · filed 2023-05-04 | $4.30M derived: sum of 2 quarters · filed 2024-02-22 | $673.00K derived: sum of 3 quarters · filed 2024-02-22 | $3.93M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.09M derived: sum of 2 quarters · filed 2024-02-22 | $4.35M derived: sum of 3 quarters · filed 2024-02-22 | $9.80M 10-K · filed 2024-02-22 | |
| 2021-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$375.00K derived: sum of 2 quarters · filed 2022-11-03 | $5.07M 10-Q · filed 2022-11-03 | $12.33M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $3.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $8.70M 10-Q · filed 2022-08-04 | $15.96M derived: sum of 3 quarters · filed 2023-02-23 | $17.34M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $5.45M 10-Q · filed 2022-05-05 | $12.70M derived: sum of 2 quarters · filed 2023-02-23 | $14.09M derived: sum of 3 quarters · filed 2023-02-23 | $14.21M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $8.64M derived: sum of 2 quarters · filed 2023-02-23 | $8.76M derived: sum of 3 quarters · filed 2023-02-23 | $9.21M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.50M derived: sum of 2 quarters · filed 2021-11-04 | $1.95M 10-Q · filed 2021-11-04 | $671.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $564.00K 10-Q · filed 2021-08-05 | -$716.00K derived: sum of 3 quarters · filed 2022-02-24 | $988.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $448.00K 10-Q · filed 2021-05-06 | -$832.00K derived: sum of 2 quarters · filed 2022-02-24 | $872.00K derived: sum of 3 quarters · filed 2022-02-24 | $2.06M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $424.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.61M derived: sum of 3 quarters · filed 2022-02-24 | $1.76M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.89M derived: sum of 2 quarters · filed 2020-11-05 | $3.04M 10-Q · filed 2020-11-05 | $3.65M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.34M 10-Q · filed 2020-08-06 | $1.94M derived: sum of 3 quarters · filed 2021-02-26 | $1.23M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $150.00K 10-Q · filed 2020-05-07 | $753.00K derived: sum of 2 quarters · filed 2021-02-26 | $39.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.04M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$111.00K derived: sum of 2 quarters · filed 2021-02-26 | $895.00K derived: sum of 3 quarters · filed 2021-02-26 | -$310.00K 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $292.00K derived: sum of 2 quarters · filed 2019-10-31 | -$913.00K 10-Q · filed 2019-10-31 | $472.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$199.00K 10-Q · filed 2019-08-01 | $1.19M derived: sum of 3 quarters · filed 2020-02-27 | $1.37M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$1.21M 10-Q · filed 2019-05-02 | $180.00K derived: sum of 2 quarters · filed 2020-02-27 | $368.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.39M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.57M derived: sum of 2 quarters · filed 2020-02-27 | $2.60M derived: sum of 3 quarters · filed 2020-02-27 | $1.89M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $1.21M derived: sum of 2 quarters · filed 2018-10-31 | $508.00K 10-Q · filed 2018-10-31 | $1.32M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $320.00K 10-Q · filed 2018-08-01 | $1.14M derived: sum of 3 quarters · filed 2019-02-27 | $892.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$704.00K 10-Q · filed 2018-05-01 | $113.00K derived: sum of 2 quarters · filed 2019-02-27 | -$132.00K derived: sum of 3 quarters · filed 2019-02-27 | $340.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $572.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.04M derived: sum of 3 quarters · filed 2019-02-27 | $979.00K 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $227.00K derived: sum of 2 quarters · filed 2017-10-31 | $162.00K 10-Q · filed 2017-10-31 | $327.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $407.00K 10-Q · filed 2017-08-01 | $572.00K derived: sum of 3 quarters · filed 2018-03-14 | $695.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | -$65.00K 10-Q · filed 2017-05-02 | $100.00K derived: sum of 2 quarters · filed 2018-03-14 | $223.00K derived: sum of 3 quarters · filed 2018-03-14 | $392.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $288.00K derived: sum of 2 quarters · filed 2018-03-14 | $457.00K derived: sum of 3 quarters · filed 2018-03-14 | $525.00K 10-K · filed 2018-03-14 | |
| 2015-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $292.00K derived: sum of 2 quarters · filed 2016-11-01 | $360.00K 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $237.00K 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | $68.00K 10-Q · filed 2016-06-03 | ||||
| 2014-12-31 | $285.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |